Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Sell Capital Senior Living Corporation (CSU)

Page 1 of 2

To the average investor, there are dozens of methods investors can use to track publicly traded companies. Two of the best are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite fund managers can beat the market by a solid margin (see just how much).

Just as crucial, positive insider trading sentiment is a second way to analyze the world of equities. Just as you’d expect, there are plenty of reasons for a corporate insider to cut shares of his or her company, but only one, very clear reason why they would behave bullishly. Several empirical studies have demonstrated the useful potential of this strategy if investors know what to do (learn more here).

Capital Senior Living Corporation

What’s more, it’s important to examine the newest info surrounding Capital Senior Living Corporation (NYSE:CSU).

What have hedge funds been doing with Capital Senior Living Corporation (NYSE:CSU)?

In preparation for the third quarter, a total of 17 of the hedge funds we track held long positions in this stock, a change of -11% from the first quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a select group of notable hedge fund managers who were upping their stakes considerably.

When using filings from the hedgies we track, Renaissance Technologies, managed by Jim Simons, holds the most valuable position in Capital Senior Living Corporation (NYSE:CSU). Renaissance Technologies has a $29.2 million position in the stock, comprising 0.1% of its 13F portfolio. The second largest stake is held by Joseph Edelman of Perceptive Advisors, with a $21.3 million position; the fund has 2.1% of its 13F portfolio invested in the stock. Remaining peers that are bullish include Phill Gross and Robert Atchinson’s Adage Capital Management, Israel Englander’s Millennium Management and Jeremy Green’s Redmile Group.

Since Capital Senior Living Corporation (NYSE:CSU) has witnessed a fall in interest from the top-tier hedge fund industry, it’s safe to say that there was a specific group of money managers who sold off their positions entirely heading into Q2. Interestingly, Richard S. Meisenberg’s ACK Asset Management sold off the biggest position of all the hedgies we key on, worth about $10.2 million in stock, and James Dondero of Highland Capital Management was right behind this move, as the fund cut about $1.2 million worth. These transactions are interesting, as total hedge fund interest was cut by 2 funds heading into Q2.

Insider trading activity in Capital Senior Living Corporation (NYSE:CSU)

Bullish insider trading is particularly usable when the company we’re looking at has seen transactions within the past half-year. Over the last half-year time period, Capital Senior Living Corporation (NYSE:CSU) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Capital Senior Living Corporation (NYSE:CSU). These stocks are Five Star Quality Care, Inc. (NYSE:FVE), Emeritus Corporation (NYSE:ESC), Kindred Healthcare, Inc. (NYSE:KND), National HealthCare Corporation (NYSEAMEX:NHC), and The Ensign Group, Inc. (NASDAQ:ENSG). This group of stocks belong to the long-term care facilities industry and their market caps are similar to CSU’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!